Mitch; Charles Howard
Patent Applications and Registrations
Patent applications and USPTO patent grants for Mitch; Charles Howard.The latest application filed is for "4-substituted-3-benzyloxy-bicyclo[3.1.0]hexane compounds as mglur 2/3 antagonists".
- Mitch; Charles Howard - Columbus IN US
| Patent | Date |
|---|---|
| 4-substituted-3-benzyloxy-bicyclo[3.1.0]hexane compounds as mGluR 2/3 antagonists Grant 9,056,844 - Dressman , et al. June 16, 2 | 2015-06-16 |
| 4-substituted-3-phenylsulfanylmethyl-bicyclo[3.1.0]hexane compounds as mGluR 2/3 antagonists Grant 8,629,169 - Smith , et al. January 14, 2 | 2014-01-14 |
| 4-SUBSTITUTED-3-BENZYLOXY-BICYCLO[3.1.0]HEXANE COMPOUNDS AS mGluR 2/3 ANTAGONISTS App 20130237573 - Dressman; Bruce Anthony ; et al. | 2013-09-12 |
| Opioid receptor antagonists Grant 8,338,611 - Mitch , et al. December 25, 2 | 2012-12-25 |
| 4-SUBSTITUTED-3-PHENYLSULFANYLMETHYL-BICYCLO[3.1.0]HEXANE COMPOUNDS AS mGluR 2/3 ANTAGONISTS App 20120129902 - SMITH; Stephon Cornell ; et al. | 2012-05-24 |
| Kappa selective opioid receptor antagonist Grant 8,173,695 - Diaz Buezo , et al. May 8, 2 | 2012-05-08 |
| Opioid Receptor Antagonists App 20110105571 - Chappell; Mark Donald ; et al. | 2011-05-05 |
| Opioid receptor antagonists Grant 7,902,372 - Chappell , et al. March 8, 2 | 2011-03-08 |
| Kappa Selective Opioid Receptor Antagonist App 20100197669 - DIAZ BUEZO; Nuria ; et al. | 2010-08-05 |
| Kappa selective opioid receptor antagonist Grant 7,709,522 - Buezo , et al. May 4, 2 | 2010-05-04 |
| Kappa Selective Opioid Receptor Antagonist App 20090186873 - Buezo; Nuria Diaz ; et al. | 2009-07-23 |
| Diaryl ethers as opioid receptor antagonists Grant 7,560,463 - Mitch , et al. July 14, 2 | 2009-07-14 |
| Diaryl ethers as opioid receptor antagonists Grant 7,531,557 - Mitch May 12, 2 | 2009-05-12 |
| Diaryl Ethers As Opioid Receptor Antagonists App 20080269296 - Blanco-Pillado; Maria-Jesus ; et al. | 2008-10-30 |
| Opioid Receptor Antagonists App 20080207701 - Chappell; Mark Donald ; et al. | 2008-08-28 |
| Opioid receptor antagonists Grant 7,414,132 - De La Torre , et al. August 19, 2 | 2008-08-19 |
| Opioid receptor antagonists Grant 7,396,943 - Benesh , et al. July 8, 2 | 2008-07-08 |
| Diaryl ethers as opioid receptor antagonist Grant 7,381,719 - Blanco-Pillado , et al. June 3, 2 | 2008-06-03 |
| Amino-phenoxymethyl-benzamide opioid receptor antagonists Grant 7,381,750 - De La Torre , et al. June 3, 2 | 2008-06-03 |
| Diphenylether amide derivatives as opioid receptor antagonists Grant 7,378,448 - Mitch , et al. May 27, 2 | 2008-05-27 |
| Opioid Receptor Antagonists App 20070287751 - De La Torre; Marta Garcia ; et al. | 2007-12-13 |
| Opioid receptor antagonists Grant 7,288,543 - Broughton , et al. October 30, 2 | 2007-10-30 |
| Opioid receptor antagonists App 20070179129 - Broughton; Howard Barff ; et al. | 2007-08-02 |
| Opioid receptor antagonists App 20070112036 - De La Torre; Marta Garcia ; et al. | 2007-05-17 |
| Opioid receptor antagonists App 20060166987 - Benesh; Dana Rae ; et al. | 2006-07-27 |
| Opioid receptor antagonists App 20050222204 - Mitch, Charles Howard ; et al. | 2005-10-06 |
| Pharmaceutical compounds App 20010012848 - Hollinshead, Sean Patrick ; et al. | 2001-08-09 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 